181 related articles for article (PubMed ID: 33029509)
1. Prognostic Role of MicroRNA 222 in Patients with Glioma: A Meta-analysis.
Song Y; Zhang J; He M; Xu J
Biomed Res Int; 2020; 2020():4689689. PubMed ID: 33029509
[TBL] [Abstract][Full Text] [Related]
2. High expression of microRNA 221 is a poor predictor for glioma.
Song Y; He M; Zhang J; Xu J
Medicine (Baltimore); 2020 Dec; 99(49):e23163. PubMed ID: 33285691
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of microvessel density in patients with glioma.
Fan C; Zhang J; Liu Z; He M; Kang T; Du T; Song Y; Fan Y; Xu J
Medicine (Baltimore); 2019 Mar; 98(9):e14695. PubMed ID: 30817605
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of miR-21 in gliomas: comprehensive study based on meta-analysis and TCGA dataset validation.
Jiang G; Mu J; Liu X; Peng X; Zhong F; Yuan W; Deng F; Peng X; Peng S; Zeng X
Sci Rep; 2020 Mar; 10(1):4220. PubMed ID: 32144351
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Role of microRNA-21 Expression in Brain Tumors: a Meta-analysis.
He XY; Liao YD; Guo XQ; Wang R; Xiao ZY; Wang YG
Mol Neurobiol; 2016 Apr; 53(3):1856-1861. PubMed ID: 25790954
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of microRNA-155 expression in gliomas: A meta-analysis.
Zhou Y; Wang X; Liu Z; Huang X; Li X; Cheng K; Jiang X
Clin Neurol Neurosurg; 2019 Jan; 176():103-109. PubMed ID: 30554090
[TBL] [Abstract][Full Text] [Related]
7. Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis.
Wu B; Sun C; Feng F; Ge M; Xia L
J Exp Clin Cancer Res; 2015 May; 34(1):44. PubMed ID: 25967234
[TBL] [Abstract][Full Text] [Related]
8. Expression of microRNA-210 and the prognosis in glioma patients: a meta-analysis.
Hu X; Yan P; Feng J; Zhang F
Biomark Med; 2020 Jun; 14(9):795-805. PubMed ID: 32715738
[No Abstract] [Full Text] [Related]
9. Prognostic and clinicopathological significance of long non-coding RNA in glioma.
Li J; Liang R; Song C; Xiang Y; Liu Y
Neurosurg Rev; 2020 Feb; 43(1):1-8. PubMed ID: 29564570
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of microRNA-21 expression in gliomas: a meta-analysis.
Li C; Sun J; Xiang Q; Liang Y; Zhao N; Zhang Z; Liu Q; Cui Y
J Neurooncol; 2016 Oct; 130(1):11-17. PubMed ID: 27531352
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of microRNA-224 confers a poor prognosis in glioma patients.
Lu S; Wang S; Geng S; Ma S; Liang Z; Jiao B
Clin Transl Oncol; 2013 Jul; 15(7):569-74. PubMed ID: 23263909
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of MicroRNAs in Glioma: A Systematic Review and Meta-Analysis.
Zhang Y; Chen J; Xue Q; Wang J; Zhao L; Han K; Zhang D; Hou L
Biomed Res Int; 2019; 2019():4015969. PubMed ID: 31032345
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of plasma miR-124 expression is a predictive biomarker for prognosis of glioma.
Wang LQ; Sun W; Wang Y; Li D; Hu AM
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):271-276. PubMed ID: 30657585
[TBL] [Abstract][Full Text] [Related]
14. A five-microRNA signature for individualized prognosis evaluation and radiotherapy guidance in patients with diffuse lower-grade glioma.
Zhang JH; Hou R; Pan Y; Gao Y; Yang Y; Tian W; Zhu YB
J Cell Mol Med; 2020 Jul; 24(13):7504-7514. PubMed ID: 32412186
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of survivin in patients with glioma.
Zhang S; Zhang C; Song Y; Zhang J; Xu J
Medicine (Baltimore); 2018 Apr; 97(17):e0571. PubMed ID: 29703049
[TBL] [Abstract][Full Text] [Related]
16. lncRNAs as potential molecular biomarkers for the clinicopathology and prognosis of glioma: A systematic review and meta-analysis.
Zhou Q; Liu J; Quan J; Liu W; Tan H; Li W
Gene; 2018 Aug; 668():77-86. PubMed ID: 29777909
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Role of BRAF Mutation in Low-Grade Gliomas: Meta-analysis.
Kai Z; Dingyang L; Zhuanyi Y
World Neurosurg; 2021 Mar; 147():42-46. PubMed ID: 33316486
[TBL] [Abstract][Full Text] [Related]
18. TERT promoter mutation and its interaction with IDH mutations in glioma: Combined TERT promoter and IDH mutations stratifies lower-grade glioma into distinct survival subgroups-A meta-analysis of aggregate data.
Vuong HG; Altibi AMA; Duong UNP; Ngo HTT; Pham TQ; Chan AK; Park CK; Fung KM; Hassell L
Crit Rev Oncol Hematol; 2017 Dec; 120():1-9. PubMed ID: 29198322
[TBL] [Abstract][Full Text] [Related]
19. Expression of CD44 and the survival in glioma: a meta-analysis.
Wu G; Song X; Liu J; Li S; Gao W; Qiu M; Yang C; Ma Y; Chen Y
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32232385
[TBL] [Abstract][Full Text] [Related]
20. Potential Diagnostic and Prognostic Value of Plasma Circulating MicroRNA-182 in Human Glioma.
Xiao Y; Zhang L; Song Z; Guo C; Zhu J; Li Z; Zhu S
Med Sci Monit; 2016 Mar; 22():855-62. PubMed ID: 26978735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
